Back to Journals » Degenerative Neurological and Neuromuscular Disease » Volume 16
Degenerative Neurological and Neuromuscular Disease
- View all (153)
- Volume 16, 2026 (9)
- Volume 15, 2025 (9)
- Volume 14, 2024 (11)
- Volume 13, 2023 (10)
- Volume 12, 2022 (11)
- Volume 11, 2021 (6)
- Volume 10, 2020 (4)
- Volume 9, 2019 (11)
- Volume 8, 2018 (8)
- Volume 7, 2017 (10)
- Volume 6, 2016 (11)
- Volume 5, 2015 (12)
- Volume 4, 2014 (13)
- Volume 3, 2013 (8)
- Volume 2, 2012 (14)
- Volume 1, 2011 (6)
Archive: Volume 16, 2026
Spermidine in Alzheimer’s Disease: Evidence from Animal Models and Human Studies
Angelucci F, Cerman J, Amlerova J, Sheardova K, Pavlik J, Hort J
Degenerative Neurological and Neuromuscular Disease 2026, 16:608341
Published Date: 20 June 2026
Marked Clinical Improvement in Parkinson’s Disease Following Double-Filtration Apheresis: A Case Report
Burgard H
Degenerative Neurological and Neuromuscular Disease 2026, 16:594425
Published Date: 12 June 2026
(Z)-Endoxifen as a Potential Modulator of Utrophin Pathways in Duchenne Muscular Dystrophy: A Mechanistic and Transcriptomic Perspective
Remmel HL, Hammer SS, Blackburn SM, Quay SC
Degenerative Neurological and Neuromuscular Disease 2026, 16:574524
Published Date: 20 May 2026
Agreement and Comparative Performance of Cognitive Testing, Visual MRI Rating, and Automated Brain Morphometry in Older Adults with Suspected Dementia in Uganda
Nassanga R, Kaddumukasa M, Jones SE, Sajatovic M, Nemani A, Basiimwa RC, Kawooya MG, Tumwine JK, Lwere K, Gumikiriza-Onoria JL, Mubuuke AG, Nakasujja N
Degenerative Neurological and Neuromuscular Disease 2026, 16:590989
Published Date: 30 April 2026
The Gut-Brain Axis in Alzheimer’s: From Microbiota Genetics to Stigmasterol’s Neuroprotection Mechanism
Ding T, Chen J, Xiang Y, Zhou X, Zheng H, Bai Y, Wang W, Fu Q, Chen Y, Fu Y
Degenerative Neurological and Neuromuscular Disease 2026, 16:580890
Published Date: 27 April 2026
Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program
Carotenuto A, Naoumis D, Brescia Morra V, Kouremenos E, Hetherington S, Arnould S, Heras VDL
Degenerative Neurological and Neuromuscular Disease 2026, 16:540207
Published Date: 15 April 2026
Emodin, a Phytotherapeutic Anthraquinone, Potently Attenuates Synaptic Redox Pathology in Aged Rats
Saha P, Ahmad F
Degenerative Neurological and Neuromuscular Disease 2026, 16:570320
Published Date: 20 February 2026
Genetic Spectrum and Phenotypic Variability in Chinese Patients with Multisystem Proteinopathy and Related Disorders
Xia X, Chen X, Sun Y, Zhang M, Qiao K, Chen Y, Zhao C, Dong Y, Zhu W
Degenerative Neurological and Neuromuscular Disease 2026, 16:568971
Published Date: 18 February 2026
Advancements in Therapy for Alzheimer’s Disease Based on the Cerebral Lymphatic System
Mi F, Ren L, Pan D, Yu C
Degenerative Neurological and Neuromuscular Disease 2026, 16:574901
Published Date: 31 January 2026